Although Tian-Song Liang has found that MicroRNA-506 can inhibit NPC tumour growth and metastasis by downregulating LHX2 [44], our study further extended the downstream targets and signalling pathway by which LHX2 serve as the oncogene in NPC, providing potential therapeutic strategies, such as FGF1/FGFR inhibitors. This evidence concerns the gene LHX2 and nasopharyngeal carcinoma.